KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Colgate Palmolive (CL) Net Income towards Common Stockholders (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Net Income towards Common Stockholders data on record, last reported at -$3.0 million in Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 100.39% year-over-year to -$3.0 million; the TTM value through Dec 2025 reached $2.3 billion, down 25.84%, while the annual FY2025 figure was $2.3 billion, 25.84% down from the prior year.
  • Net Income towards Common Stockholders reached -$3.0 million in Q4 2025 per CL's latest filing, down from $765.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $778.0 million in Q4 2024 and bottomed at -$3.0 million in Q4 2025.
  • Average Net Income towards Common Stockholders over 5 years is $603.5 million, with a median of $727.0 million recorded in 2021.
  • Peak YoY movement for Net Income towards Common Stockholders: soared 1667.44% in 2023, then crashed 100.39% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $188.0 million in 2021, then plummeted by 77.13% to $43.0 million in 2022, then skyrocketed by 1667.44% to $760.0 million in 2023, then increased by 2.37% to $778.0 million in 2024, then plummeted by 100.39% to -$3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$3.0 million in Q4 2025, $765.0 million in Q3 2025, and $773.0 million in Q2 2025.